GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that ...
For researchers, including Georgetown University chemist Jennifer Swift, analyzing reptilian pee crystals presented an ...
Crystals "peed" by snakes could hold the key to treating kidney stones and gout in humans, say scientists. Researchers ...
Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics, Inc. (“Crystalys”), in which Urica ...
MedPage Today on MSN
Tainted Egg Warning; Dialysis Clinic Investigation; Gout Drug Flops for Long COVID
The FDA warned that Kenz Henz recalled some of its eggs due to potential Salmonella contamination. Republican leaders are ...
Unless you've owned reptiles, you might not know that many of them "pee" crystals. Researchers publishing in the Journal of ...
High uric acid, or Hyperuricemia is a condition when your body produces too much uric acid, a waste product from the ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
TipRanks on MSN
XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2025, XORTX Therapeutics Inc. announced a securities purchase ...
TipRanks on MSN
XORTX Receives Nasdaq Notification for Bid Price Deficiency
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 20, 2025, XORTX Therapeutics Inc. announced it received a notification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results